Shareholder alert: weiss law investigates radius health, inc.

New york , june 27, 2022 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of radius health, inc. ("radius health" or the "company") (nasdaq: rdus), in connection with the proposed acquisition of the company by gurnet point capital and patient square capital via tender offer.  under the terms of the merger agreement, the company's shareholders will receive $ 10.00 per share plus a contingent value right (cvr) of $1.00 per share payable upon tymlos® net sales reaching $300 million during any consecutive 12-month period prior to december 31, 2025.
RDUS Ratings Summary
RDUS Quant Ranking